Pharmacotherapy of cognitive deficits in Alzheimer's disease and age-associated memory impairment.
作者信息
Crook T
出版信息
Psychopharmacol Bull. 1988;24(1):31-8.
PMID:3290945
Abstract
摘要
相似文献
1
Pharmacotherapy of cognitive deficits in Alzheimer's disease and age-associated memory impairment.
Psychopharmacol Bull. 1988;24(1):31-8.
2
Memory problems in dementia: adaptation and coping strategies and psychosocial treatments.痴呆症的记忆问题：适应和应对策略及心理社会治疗。
Expert Rev Neurother. 2011 Dec;11(12):1769-81; quiz 1782. doi: 10.1586/ern.11.167.
3
Effects of beta-hydroxybutyrate on cognition in memory-impaired adults.β-羟基丁酸对记忆受损成年人认知功能的影响。
Neurobiol Aging. 2004 Mar;25(3):311-4. doi: 10.1016/S0197-4580(03)00087-3.
4
Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits.阿尔茨海默病中的疾病失认症：与患者特征、精神症状及认知缺陷的关联
Psychiatry Clin Neurosci. 2005 Dec;59(6):697-704. doi: 10.1111/j.1440-1819.2005.01439.x.
5
Therapeutics of Alzheimer's disease for clinical and pre-clinical issues.用于临床和临床前问题的阿尔茨海默病治疗方法。
Prog Clin Biol Res. 1989;317:1111-20.
6
Rofecoxib in mild cognitive impairment.罗非昔布与轻度认知障碍
Curr Psychiatry Rep. 2006 Feb;8(1):9-10.
7
Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment.睾酮可改善患有阿尔茨海默病和轻度认知障碍男性的空间记忆。
Neurology. 2005 Jun 28;64(12):2063-8. doi: 10.1212/01.WNL.0000165995.98986.F1.
8
[News on the Alzheimer's disease].[关于阿尔茨海默病的新闻]
Ann Pharm Fr. 2009 Mar;67(2):67-8. doi: 10.1016/j.pharma.2008.12.001. Epub 2009 Jan 29.
9
Galantamine for Alzheimer's disease and mild cognitive impairment.加兰他敏用于治疗阿尔茨海默病和轻度认知障碍。
Neuroepidemiology. 2007;28(2):116-7. doi: 10.1159/000101510. Epub 2007 Apr 4.
10
[Awareness of memory deficits in patients with probable Alzheimer's disease].[对可能患有阿尔茨海默病患者记忆缺陷的认知]
Fortschr Neurol Psychiatr. 2005 Jun;73(6):327-32. doi: 10.1055/s-2004-830245.
引用本文的文献
1
Cognitive impairment in elderly people. Predisposing factors and implications for experimental drug studies.老年人的认知障碍。诱发因素及对实验性药物研究的影响。
Drugs Aging. 1995 Dec;7(6):459-79. doi: 10.2165/00002512-199507060-00006.
2
Ginkgo biloba extract and cognitive decline.银杏叶提取物与认知衰退
Br J Clin Pharmacol. 1993 Aug;36(2):137. doi: 10.1111/j.1365-2125.1993.tb04213.x.
3
Tetrahydroaminoacridine (THA) in Alzheimer's disease.四氢氨基吖啶（THA）与阿尔茨海默病
BMJ. 1989 Apr 1;298(6677):845-6. doi: 10.1136/bmj.298.6677.845.
4
Are drugs targeted at Alzheimer's disease useful? 2. Insufficient evidence of worthwhile benefit.治疗阿尔茨海默病的药物有用吗？2. 缺乏有价值益处的充分证据。
BMJ. 1990 Apr 28;300(6732):1132-3; discussion 1131. doi: 10.1136/bmj.300.6732.1132.
5
Co-dergocrine mesylate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in age-related cognitive decline.甲磺酸双氢麦角隐亭。其药效学、药代动力学特性及在年龄相关性认知功能减退中的治疗应用综述
Drugs Aging. 1992 May-Jun;2(3):153-73. doi: 10.2165/00002512-199202030-00002.
Zotero 插件